Feedback Share Discussion Threads

[digger2779] 26/4/2020 17:38

I have seen the word "imminent" misused so many times that we should ask the Oxford Dictionary to add an optional definition :- "when used in business management speak" it means this will occur or already has occurred in some parallel universe but will not manifest itself in the real world any time soon or if at all.

[ducatiman] 26/4/2020 17:24

Lol, didn’t stop rollout to Penine trust. Does it really matter? Maybe they have it already but haven’t announced it yet. British kite mark next!?

[lr2] 26/4/2020 17:22

Gerard J Brandon still has his eye on Feedback.

[zooskeeper] 26/4/2020 16:40

CE approval ‘imminent̵7; entering fourth week! What is the point of doing Q&A to loyal shareholders when mislead

[ducatiman] 26/4/2020 15:28

Luke, agreed, though it could be contained in a general update.

[lukehold] 26/4/2020 14:33

Im a shareholder here but I don’t believe a 80 word post on a daily blog about feedback using AWS warrants a RNS. Talk about rampy.

Also what are the 99 other company’s falsely claiming to be in use you refer to?

[pwhite73] 26/4/2020 13:36

Ged5

Good find. I stated in my very first post FDBK's communication is very poor. They have a product that is actually in use unlike 99% of these jam tomorrow AIM companies. The Amazon and the ADIH stories should be RNS news.

[ducatiman] 26/4/2020 10:42

Good to GO!

[meganxmas] 26/4/2020 09:57

Amazon news has 139k followers albeit I suspect mainly US based.

[meganxmas] 26/4/2020 09:49

Yes hopefully this is indicative of something significant. But even if not more that pennine at the moment at very least is fantastic exposure.

[ged5] 26/4/2020 09:45

I see Amazon News has re-tweeted their blog this morning but prefaced it with:-

"With the support of @awscloud, @FBKmed can scale its software platform for National Health Service providers in the UK and help speed up the review of medical images."



Could be interesting to see how this develops. Remember Tom Oakley recently mentioned Amazon and Microsoft in a recent Q&A session.

[ged5] 26/4/2020 09:29

Thanks LR2 for the link to the abstract to investigate MRI based texture analysis in predicting overall survival in childhood diffuse midline gliomas of the pons.

It seems only about 6033 people are living with this tumor,344 children each year, so great to see research being done on something which affects a small number of people. If one knew someone who suffers from this tumor it would be a relief to be told there was a good chance of survival.



With all the research that goes on with TexRAD it would be good if for once we got a clinical development.

Sell or develop but let it benefit FDBK.

Slight correction to an earlier post. I misread Friday's RNS. I see the options are in lieu of salary raise and bonus. They're not in place of salary as I had first interpreted.

[sonie01] 25/4/2020 21:06

I agree LR2, there is also the option of interest free (although initially only interest free for the first 12 months) loans backed 80% by the govt because of the environment we are in. The govt backed loans would be the preferred method to raise funds as the liability of the loan is thus: 80% govt, 20% company. Also, if they are confident of getting contracts, then once monetised, the revenue would service the loansIt will be interesting to see which route they take to raise funds, as potentially this could tell us where they are at. Of course, any comments would be welcom from fellow investors

[ducatiman] 25/4/2020 19:58

Indeed LR2!

[lr2] 25/4/2020 18:34

If they have absolute confidence in future Bleepa contracts I can see the possibility of them selling TexRAD to a bigger company rather than dilute shareholdings with another placing. No point in granting themselves options just prior to a placing after all.

[davydoo] 25/4/2020 18:03

'rolled out by the NHS' is a bit of stretch, but things look good. Extra development is burning that cash faster than previously expected I imagine, timing the next fund raise is crucial

Certainly seems poised for more though right now

[ducatiman] 25/4/2020 16:17

Texrad still there LR2!! Have a good feeling about this company these days, hasn’t always been the case.

[lr2] 25/4/2020 15:26

Predicting outcome in childhood diffuse midline gliomas using magnetic resonance imaging based texture analysis - 23/04/20



"Retrospective study of patients diagnosed with DMG, based on radiological features, treated at our institution 2007–2017. MRIs were acquired at diagnosis and 6 weeks after radiotherapy (54Gy in 30 fractions). MRTA was performed using commercial available TexRAD research software on T2W sequence and Apparent Diffusion Coefficient (ADC) maps encapsulating tumour in the largest single axial plane. MRTA comprised filtration-histogram technique using statistical and histogram metrics for quantification of texture. Kaplan-Meier survival analysis determined association of MRI texture parameters with OS."

[bunz3] 25/4/2020 13:12

IF YOU NOT GETTING A RPLY FROM PWITE
CLUE WHERE YOU FIND POSTING
ESPECIALLY NEXT WEEK IF
RNS SEEN THERE

[yump] 24/4/2020 15:33

So please provide a reference to the survey where 500 companies were examined to see whether poor communication with shareholders correlates with poor communication within the business.

Or work for the media - they're good at expanding small bits of 'evidence' into general sweeping conclusions, which have nothing except face-validity.

The first problem will be defining what you mean by 'poor communication'. No actually please don't - you can just make up anything you want subjectively.

Come to think of it the name of the company is terrible communication and a reason to ditch all my shares: "Feedback" ?? In what way exactly does that name related to the business itself.

and as for Google...

[pwhite73] 24/4/2020 13:49

This company suffers from poor communications. Where you find poor communication to the stock markets you will find it in business generally. Options at 1.20p so soon after probably their biggest announcement either shows greed or lack of confidence. It really is a shame for this is one of the very few companies that actually has product readily usable to assist in the combat against Covid-19.